Cargando…
A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death
BACKGROUND: Clarithromycin, known as a potent inhibitor of the cytochrome P450 isoenzyme CYP3A, may increase the plasma concentration of statins metabolized by this pathway; therefore, increase the risk of interaction with statins in reference to pharmacokinetic studies. This study aimed to characte...
Autores principales: | Mesgarpour, Bita, Gouya, Ghazaleh, Herkner, Harald, Reichardt, Berthold, Wolzt, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619489/ https://www.ncbi.nlm.nih.gov/pubmed/26497728 http://dx.doi.org/10.1186/s12944-015-0134-y |
Ejemplares similares
-
Search strategies to identify reports on “off-label” drug use in EMBASE
por: Mesgarpour, Bita, et al.
Publicado: (2012) -
Thrombus formation is not pH-dependent
por: Weisshaar, Stefan, et al.
Publicado: (2010) -
SSRI co‐medication with NOAC or VKA does not increase hospitalisation for bleeding: A retrospective nationwide cohort study in Austria 2010‐2015
por: Sheikh Rezaei, Safoura, et al.
Publicado: (2019) -
Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects
por: Oh, Minkyung, et al.
Publicado: (2023) -
Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
por: Ruan, Xu Cong, et al.
Publicado: (2019)